These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6913222)

  • 21. [Therapeutic effectiveness of modern antiparkinson agents].
    Kurako IuL; Volianskiĭ VE; Fadeev SM
    Vrach Delo; 1981 Feb; (2):7-11. PubMed ID: 7222616
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary lingual dystonia induced by speaking.
    Baik JS; Park JH; Kim JY
    Mov Disord; 2004 Oct; 19(10):1251-2. PubMed ID: 15390005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fatalities caused by anticholinergic antiparkinsonian drugs. Analysis of findings in a 11-year national material].
    Gjerden P; Engelstad KS; Pettersen G; Slørdal L
    Tidsskr Nor Laegeforen; 1998 Jan; 118(1):42-4. PubMed ID: 9481909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stage-adjusted treatment of idiopathic Parkinson syndrome].
    Ludin HP
    Wien Med Wochenschr; 1995; 145(13):294-8. PubMed ID: 7571654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parkinson's disease: focus on management alternatives.
    Young LR; Justice LN
    Am J Manag Care; 2000 Jan; 6(1):93-113; quiz 114-6. PubMed ID: 11009750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats.
    Myhrer T; Enger S; Aas P
    Pharmacol Biochem Behav; 2008 Jun; 89(4):633-8. PubMed ID: 18384867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients.
    Leoni O; Martignoni E; Cosentino M; Michielotto D; Calandrella D; Zangaglia R; Riboldazzi G; Oria C; Lecchini S; Nappi G; Frigo G
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):149-57. PubMed ID: 11998540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical evaluation of a new anticholinergic drug, pro-banthine.
    SCHWARTZ IR; LEHMAN E; OSTROVE R; SEIBEL JM
    Gastroenterology; 1953 Nov; 25(3):416-30. PubMed ID: 13107938
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of idiopathic Parkinson syndrome 1817 to 2001. A success story?].
    Ludin HP
    Praxis (Bern 1994); 2001 Jun; 90(23):1009-14. PubMed ID: 11447720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical appraisal of pentapiperide methylsulfate a new anticholinergic drug.
    SMITH VM; MEAD JA; IDEA BV; MALLARI RP
    Am J Gastroenterol; 1963 Jan; 39():52-60. PubMed ID: 13989590
    [No Abstract]   [Full Text] [Related]  

  • 32. A survey of antipsychotic treatment for schizophrenia in Hong Kong.
    Yip KC; Ungvari GS; Cheung HK; Ng FS; Lau ST
    Chin Med J (Engl); 1997 Oct; 110(10):792-6. PubMed ID: 9642312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parcopa: a rapidly dissolving formulation of carbidopa/levodopa.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):12. PubMed ID: 15706700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of an anticholinergic antiparkinsonian drug, parkinsonism, and psychotic symptoms on cardiac autonomic function in schizophrenia.
    Okada T; Toichi M; Sakihama M
    J Clin Psychopharmacol; 2003 Oct; 23(5):441-7. PubMed ID: 14520119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticholinergic drug use and bowel function in nursing home patients.
    Monane M; Avorn J; Beers MH; Everitt DE
    Arch Intern Med; 1993 Mar; 153(5):633-8. PubMed ID: 8439226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug therapy of Parkinson's disease].
    Myllylä V
    Duodecim; 1997; 113(18):1827-34. PubMed ID: 10892076
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
    Millan MJ; Maiofiss L; Cussac D; Audinot V; Boutin JA; Newman-Tancredi A
    J Pharmacol Exp Ther; 2002 Nov; 303(2):791-804. PubMed ID: 12388666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiparkinson agents].
    van der Kuy A; van der Bemd AA; Beysens AJ
    Tijdschr Ziekenverpl; 1977 Apr; 30(8):377-8. PubMed ID: 585506
    [No Abstract]   [Full Text] [Related]  

  • 39. Know your generics.
    Teplitsky B
    Okla Nurse; 1981 Mar; 26(1):13. PubMed ID: 6907818
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug information: antiparkinson agents. I. Anticholinergic agents].
    Veje VO
    Sygeplejersken; 1981 Sep; 81(34):11. PubMed ID: 6913222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.